home / stock / totau / totau short
Short Information | Tottenham Acquisition I Limited Unit (NASDAQ:TOTAU)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 27,624 |
Total Actual Volume | 1,268,730 |
Short Trends | |
---|---|
Cover Days | 11 |
Short Days | 2 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 1,381 |
Average Short Percentage | 14.24% |
Is there a TOTAU Short Squeeze or Breakout about to happen?
See the TOTAU Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-29-2020 | $21.6 | $20 | $21.6 | $20 | 955 | 100 | 10.47% |
01-23-2019 | $N/A | $10.24 | $N/A | $N/A | 200 | 181 | 90.5% |
01-22-2019 | $10.20 | $10.24 | $10.24 | $10.20 | 4,807 | 1,609 | 33.47% |
01-02-2019 | $10.20 | $10.20 | $10.20 | $10.20 | 278 | 28 | 10.07% |
12-28-2018 | $10.1959 | $10.199 | $10.20 | $10.1959 | 2,836 | 1,468 | 51.76% |
12-04-2018 | $10.24 | $10.20 | $10.24 | $10.00 | 4,900 | 1,000 | 20.41% |
09-17-2018 | $10.25 | $10.40 | $10.40 | $10.23 | 4,080 | 933 | 22.87% |
09-13-2018 | $10.28 | $10.35 | $10.35 | $10.28 | 59,279 | 700 | 1.18% |
08-14-2018 | $10.16 | $10.14 | $10.16 | $10.14 | 97,600 | 3,400 | 3.48% |
08-10-2018 | $10.18 | $10.17 | $10.20 | $10.16 | 7,415 | 2,465 | 33.24% |
08-08-2018 | $10.20 | $10.21 | $10.22 | $10.18 | 152,030 | 2,350 | 1.55% |
08-03-2018 | $10.13 | $10.12 | $10.1499 | $10.12 | 67,800 | 3,190 | 4.71% |
08-02-2018 | $10.12 | $10.13 | $10.15 | $10.12 | 866,550 | 10,200 | 1.18% |
News, Short Squeeze, Breakout and More Instantly...
Tottenham Acquisition I Limited Unit Company Name:
TOTAU Stock Symbol:
NASDAQ Market:
NEW YORK , Sept. 10, 2020 /PRNewswire/ -- Tottenham Acquisition I Limited (Nasdaq: TOTA, TOTAU, TOTAW, TOTAR) ("Tottenham"), a publicly traded special purpose acquisition company, announced today that its subsidiary, Chelsea Worldwide Inc., has filed with the U.S. Securities and Exchang...
Clene is a clinical-stage biopharmaceutical company developing the first potential therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the n...
NEW YORK , July 29, 2019 /PRNewswire/ -- Tottenham Acquisition I Limited (NASDAQ: TOTAU, the "Company"), a special purpose acquisition company, announced today that Norwich Investment Limited, the Company's initial public offering sponsor (" Norwich "), has deposited into the Company's tr...